Your browser doesn't support javascript.
loading
Lymphopenia associated with whole-brain radiotherapy and its effects on clinical outcomes of patients with brain metastases.
Wang, Yue; Zeng, Weiwei; Xie, Wenyue; Zhao, Wei; Chen, Yonghong; Yang, Guiping.
Afiliación
  • Wang Y; Department of Oncology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Zeng W; Department of Oncology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Xie W; Department of Oncology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. xwy123@hospital.cqmu.edu.cn.
  • Zhao W; Department of Oncology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Chen Y; Department of Oncology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Yang G; Department of Oncology, People's Hospital of Xiushan Tujia and Miao Autonomous County, Chongqing, China.
Sci Rep ; 14(1): 21315, 2024 09 12.
Article en En | MEDLINE | ID: mdl-39266704
ABSTRACT
There is increasing awareness of radiotherapy's potential side effects, such as lymphopenia. Therefore, this study aimed to establish the association between WBRT and the development of lymphopenia in patients with brain metastases undergoing brain radiotherapy (RT), along with evaluating the corresponding clinical outcomes. Including 116 patients with brain metastases undergoing brain radiotherapy, the study collected the absolute lymphocyte counts (ALC) within 2 weeks before brain radiotherapy (pre-radiotherapy, pre-RT), as well as ones at 1 and 2 months after completing RT (post-RT). Univariate and multivariate analyses were performed to identify associations between radiation modality and post-RT ALC. The relationships between post-RT ALC and overall survival were evaluated with Kaplan-Meier analysis and a multivariate Cox regression model. The median ALC definitely decreased at 1 month post-RT, but at 2 months post-RT, gradually rose but not to the pre-RT ALC. The multivariate analysis identified WBRT and lower pre-RT ALC as independent risk factors associated with the decrease in post-RT ALC at 1 month. It also revealed more than 4 brain metastases, G3-4 lymphopenia at 1 month and lower post-RT ALC at 2 months exhibited significantly worse prognosis regardless of the radiation modality. However, there was indeed an independent correlation between radiation modality and the outcome of intracranial progression-free survival (PFS). To approach the feasibility and reasonableness of treatment, clinicians should carefully consider various factors to achieve long-term survival of patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Irradiación Craneana / Linfopenia Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Irradiación Craneana / Linfopenia Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido